Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis.
- 2025-06-04
- Meta-Analysis · n = 1,125
- Frontiers in cellular and infection microbiology 15
- Lynne V McFarland
- Tong Li
- PubMed: 40535538
- DOI: 10.3389/fcimb.2025.1587792
- High evidence
- Clinical
S. boulardii CNCM I-745 was found to significantly reduce the duration of PAGE (SMD=-1.63 days, 95% CI -2.08, -1.18)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes